Juvenile Idiopathic Arthritis (JIA)
20
10
11
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
10.0%
2 terminated out of 20 trials
60.0%
-26.5% vs benchmark
20%
4 trials in Phase 3/4
100%
3 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (20)
OLE Study With Filgotinib in JIA
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic Diseases
HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis
Tofacitinib in Juvenile Idiopathic Arthritis
Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIA
Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis
Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients
Cognitive Exercise Therapy Approach (BETY) in JIA
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
CAPRI National Juvenile Idiopathic Arthritis Registry
Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis
Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis
Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)
Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole System
Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission